This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2016.
Company Filing History:
Years Active: 2016
Certainly! Here is the article about inventor Upkar Bhardwaj:
Title: Unveiling the Innovations of Upkar Bhardwaj - A Pioneer in Pharmaceutical Formulations
Introduction: Upkar Bhardwaj, a distinguished inventor based in Coram, New York, has been revolutionizing the pharmaceutical industry with his groundbreaking creations. With a keen eye for detail and a passion for innovation, Bhardwaj has made significant contributions to the field of healthcare.
Latest Patents: Bhardwaj holds a notable patent for the 'Immediate Release 4-Methyl-3-4[[4-(3-Pyridinyl)-2-Pyrimidinyl]amino]-N-[5-(4-Methyl-1H-Imidazol-1-YL)-3-(Trifluoromethyl)Phenyl] Benzamide Formulation.' This solid dosage form of nilotinib incorporates a core comprising specific components and polymers, allowing for delayed disintegration of the dosage form.
Career Highlights: Currently affiliated with Novartis AG, a renowned pharmaceutical company, Bhardwaj's expertise and innovative mindset have propelled him to success in the industry. His dedication to research and development has led to the creation of impactful solutions for various medical challenges.
Collaborations: Bhardwaj has had the privilege of working alongside talented individuals in his field, including Ann Reese Comfort and Ping Li. These collaborations have fostered a culture of creativity and excellence, driving forward the boundaries of pharmaceutical innovation.
Conclusion: Upkar Bhardwaj's inventive spirit and commitment to excellence continue to inspire those around him. His contributions to the pharmaceutical sector showcase not only his technical prowess but also his unwavering dedication to improving healthcare outcomes. With a patent portfolio reflecting his ingenuity, Bhardwaj stands as a beacon of innovation in the realm of pharmaceutical formulations.
Would you like to know more about other inventors or their patents?